Latest news
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - Barron'sBarron's · Tue, 04 Aug 2026 21:27:00 GMTBioNTech cuts sales forecast on slumping demand for COVID-19 vaccine - BioSpaceBioSpace · Tue, 04 Aug 2026 14:56:30 GMTPfizer lifts revenue outlook as non-COVID portfolio offsets sales decline - The Pharma LetterThe Pharma Letter · Tue, 04 Aug 2026 14:40:35 GMTLower Demand for Vaccines: BioNTech Deep in the Red - bluewin.chbluewin.ch · Tue, 04 Aug 2026 13:06:00 GMTWhat we’ve learned about Covid-19 since the pandemic - CNNCNN · Tue, 04 Aug 2026 10:00:25 GMTPoland appeals €1.3B Pfizer vaccine ruling - politico.eupolitico.eu · Mon, 03 Aug 2026 17:28:00 GMTPfizer-BioNTech COVID vaccine authorized in EU for 2026-2027 season - eciks.orgeciks.org · Sat, 01 Aug 2026 07:13:46 GMTEuropean Commission authorizes Pfizer-BioNTech COVID vaccine targeting XFG variant - eciks.orgeciks.org · Fri, 31 Jul 2026 11:34:59 GMT